In the Literature: On Clinical Performance Measures and Outcomes Among Hemodialysis Patients
Author:
- Patrick S. ParfreyPPPatrick S. Parfrey
- 1 March 2007
- journal article
- editorial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 49 (3) , 352-355
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and AnemiaNew England Journal of Medicine, 2006
- Association of Achieved Dialysis Dose with Mortality in the Hemodialysis StudyJournal of the American Society of Nephrology, 2005
- Double-Blind Comparison of Full and Partial Anemia Correction in Incident Hemodialysis Patients without Symptomatic Heart DiseaseJournal of the American Society of Nephrology, 2005
- The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)JACC, 2005
- Influence of target hemoglobin in dialysis patients on morbidity and mortalityKidney International, 2002
- The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and EpoetinNew England Journal of Medicine, 1998
- The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal diseaseAmerican Journal of Kidney Diseases, 1996
- Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.BMJ, 1990
- Effect of the Hemodialysis Prescription on Patient MorbidityNew England Journal of Medicine, 1981